Abstract
CHANGES in the concentrations of several enzymes in leukaemic leucocytes have been reported, including increases in acid phosphatase1, dihydrofolate reductase2, and the first three enzymes in the pathway for the de novo biosynthesis of pyrimidine3. A reduction in the activity of some enzymes has also been reported, for example, alkaline phosphatase4,5, lactic dehydrogenase6 and deoxythymidine phosphorylase7. In general, it is not clear whether these changes in concentrations are caused by abnormalities of the leukaemic process itself, or simply the consequence of a decrease in the percentage of mature cells in the peripheral blood. It is therefore important to show that the enzyme defect persists in the presence of a complete clinical and haematological remission. There have so far been few reports dealing with this question. This is partly because of the difficulty of procuring sufficient leucocytes for study because patients in remission have normal or low normal white blood cell counts. Thus most documented cases of enzyme abnormalities in leukaemia have been reported from studies with immature cells. Exceptions to this are the observations on the concentrations of leucocyte alkaline phosphatase (AP). This enzyme is low or absent in the leucocytes of patients with chronic myelogenous leukaemia (CML)4,5, and remains low in some patients in remission even though the number of mature cells in the peripheral blood is normal4,5,8,9.
Similar content being viewed by others
References
Valentine, W. N., and Beck, W. S., J. Lab. Clin. Med., 38, 39 (1951).
Bertino, J. R., Silber, R., Freeman, M., Alenty, A., Albrecht, M., Gabrio, B. W., and Huennekens, F. M., J. Clin. Invest., 42, 1899 (1963).
Smith, L. H., Baker, F. A., and Sullivan, M., Blood, 15, 360 (1960).
Valentine, W. N., Follette, J. H., Solomon, D. H., and Reynolds, J., J. Lab. Clin. Med., 49, 723 (1957).
Xefteris, E., Mitus, W. J., Mednicoff, I. B., and Dameshek, W., Blood, 18, 202 (1961).
Rabinowitz, Y., Blood, 27, 470 (1966).
Marsh, J. C., and Perry, S., J. Clin. Invest., 43, 267 (1964).
Frei, E., III, Tjio, J. H., Whang, J., and Carbone, P. P., Ann. NY Acad. Sci., 113, 1073 (1964).
Block, J. B., Carbone, P. P., Oppenheim, J. J., and Frei, E., III, Ann. Intern. Med., 59, 629 (1963).
Gallo, R. C., Perry, S., and Breitman, T. R., J. Biol. Chem., 242, 5059 (1967).
Gallo, R. C., Perry, S., and Breitman, T. R., Clin. Res., 15, 277 (1967).
Morse, E. E., Carbone, P. P., Freireich, E. J., Bronson, W., and Kliman, A., Transfusion, 6, 175 (1966).
Fallon, H. J., Frei, E., Davidson, J. D., Trier, J. S., and Burk, D., J. Lab. Clin. Med., 59, 779 (1962).
Greenwalt, T. J., Gajewski, M., and McKenna, J. L., Transfusion, 2, 221 (1962).
Natrella, M. G., Experimental Statistics, National Bureau of Standards Handbook 91 (US Government Printing Office, Washington, DC, 1963).
Nowell, P. C., and Hungerford, D. A., J. Nat. Cancer Inst., 25, 85 (1960).
Baikie, A. G., Court-Brown, W. M., Buckton, K. E., Harnden, D. G., Jacobs, P. A., and Tough, I. M., Nature, 188, 1165 (1960).
Peacock, A. C., Brecher, G., and Highsmith, E. M., Amer. J. Clin. Pathol., 29, 80 (1958).
Gallo, R. C., Perry, S., and Breitman, T. R., Blood, 30, 857 (1967).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. Biol. Chem., 193, 265 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GALLO, R., PERRY, S. Enzyme Abnormality in Human Leukaemia. Nature 218, 465–466 (1968). https://doi.org/10.1038/218465a0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1038/218465a0
- Springer Nature Limited